ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Enasidenib Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-38A12006
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Enasidenib Drugs Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Enasidenib Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-38A12006
Report
September 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb

Enasidenib Drugs - Market Size

The global market for Enasidenib Drugs was estimated to be worth US$ 78 million in 2023 and is forecast to a readjusted size of US$ 125.9 million by 2030 with a CAGR of 7.1% during the forecast period 2024-2030

Enasidenib Drugs - Market

Enasidenib Drugs - Market

Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enasidenib Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enasidenib Drugs by region & country, by Type, and by Application.
The Enasidenib Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enasidenib Drugs.
Market Segmentation

Scope of Enasidenib Drugs - Market Report

Report Metric Details
Report Name Enasidenib Drugs - Market
Forecasted market size in 2030 US$ 125.9 million
CAGR 7.1%
Forecasted years 2024 - 2030
Segment by Type:
  • 50mg
  • 100mg
Segment by Application
  • Hospital
  • Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol Myers Squibb
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Enasidenib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Enasidenib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Enasidenib Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Enasidenib Drugs - Market size in 2030?

Ans: The Enasidenib Drugs - Market size in 2030 will be US$ 125.9 million.

Who are the main players in the Enasidenib Drugs - Market report?

Ans: The main players in the Enasidenib Drugs - Market are Bristol Myers Squibb

What are the Application segmentation covered in the Enasidenib Drugs - Market report?

Ans: The Applications covered in the Enasidenib Drugs - Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Enasidenib Drugs - Market report?

Ans: The Types covered in the Enasidenib Drugs - Market report are 50mg, 100mg

1 Market Overview
1.1 Enasidenib Drugs Product Introduction
1.2 Global Enasidenib Drugs Market Size Forecast
1.2.1 Global Enasidenib Drugs Sales Value (2019-2030)
1.2.2 Global Enasidenib Drugs Sales Volume (2019-2030)
1.2.3 Global Enasidenib Drugs Sales Price (2019-2030)
1.3 Enasidenib Drugs Market Trends & Drivers
1.3.1 Enasidenib Drugs Industry Trends
1.3.2 Enasidenib Drugs Market Drivers & Opportunity
1.3.3 Enasidenib Drugs Market Challenges
1.3.4 Enasidenib Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Enasidenib Drugs Players Revenue Ranking (2023)
2.2 Global Enasidenib Drugs Revenue by Company (2019-2024)
2.3 Global Enasidenib Drugs Players Sales Volume Ranking (2023)
2.4 Global Enasidenib Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Enasidenib Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Enasidenib Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Enasidenib Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Enasidenib Drugs
2.9 Enasidenib Drugs Market Competitive Analysis
2.9.1 Enasidenib Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Enasidenib Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 50mg
3.1.2 100mg
3.2 Global Enasidenib Drugs Sales Value by Type
3.2.1 Global Enasidenib Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Enasidenib Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Enasidenib Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Enasidenib Drugs Sales Volume by Type
3.3.1 Global Enasidenib Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Enasidenib Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Enasidenib Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Enasidenib Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Enasidenib Drugs Sales Value by Application
4.2.1 Global Enasidenib Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Enasidenib Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Enasidenib Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Enasidenib Drugs Sales Volume by Application
4.3.1 Global Enasidenib Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Enasidenib Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Enasidenib Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Enasidenib Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Enasidenib Drugs Sales Value by Region
5.1.1 Global Enasidenib Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Enasidenib Drugs Sales Value by Region (2019-2024)
5.1.3 Global Enasidenib Drugs Sales Value by Region (2025-2030)
5.1.4 Global Enasidenib Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Enasidenib Drugs Sales Volume by Region
5.2.1 Global Enasidenib Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Enasidenib Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Enasidenib Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Enasidenib Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Enasidenib Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Enasidenib Drugs Sales Value, 2019-2030
5.4.2 North America Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Enasidenib Drugs Sales Value, 2019-2030
5.5.2 Europe Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Enasidenib Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Enasidenib Drugs Sales Value, 2019-2030
5.7.2 South America Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Enasidenib Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Enasidenib Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Enasidenib Drugs Sales Value
6.2.1 Key Countries/Regions Enasidenib Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Enasidenib Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Enasidenib Drugs Sales Value, 2019-2030
6.3.2 United States Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Enasidenib Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Enasidenib Drugs Sales Value, 2019-2030
6.4.2 Europe Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Enasidenib Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Enasidenib Drugs Sales Value, 2019-2030
6.5.2 China Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Enasidenib Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Enasidenib Drugs Sales Value, 2019-2030
6.6.2 Japan Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Enasidenib Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Enasidenib Drugs Sales Value, 2019-2030
6.7.2 South Korea Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Enasidenib Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Enasidenib Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Enasidenib Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Enasidenib Drugs Sales Value, 2019-2030
6.9.2 India Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Enasidenib Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Information
7.1.2 Bristol Myers Squibb Introduction and Business Overview
7.1.3 Bristol Myers Squibb Enasidenib Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bristol Myers Squibb Enasidenib Drugs Product Offerings
7.1.5 Bristol Myers Squibb Recent Development
8 Industry Chain Analysis
8.1 Enasidenib Drugs Industrial Chain
8.2 Enasidenib Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Enasidenib Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Enasidenib Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
List of Tables
    Table 1. Enasidenib Drugs Market Trends
    Table 2. Enasidenib Drugs Market Drivers & Opportunity
    Table 3. Enasidenib Drugs Market Challenges
    Table 4. Enasidenib Drugs Market Restraints
    Table 5. Global Enasidenib Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Enasidenib Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Enasidenib Drugs Sales Volume by Company (2019-2024) & (Units)
    Table 8. Global Enasidenib Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Enasidenib Drugs Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Enasidenib Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Enasidenib Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Enasidenib Drugs
    Table 13. Global Enasidenib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Enasidenib Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Enasidenib Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Enasidenib Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Enasidenib Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Enasidenib Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Enasidenib Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)
    Table 22. Global Enasidenib Drugs Sales Volume by Type (2019-2024) & (Units)
    Table 23. Global Enasidenib Drugs Sales Volume by Type (2025-2030) & (Units)
    Table 24. Global Enasidenib Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Enasidenib Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Enasidenib Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Enasidenib Drugs Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Enasidenib Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Enasidenib Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Enasidenib Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Enasidenib Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Enasidenib Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Enasidenib Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)
    Table 34. Global Enasidenib Drugs Sales Volume by Application (2019-2024) & (Units)
    Table 35. Global Enasidenib Drugs Sales Volume by Application (2025-2030) & (Units)
    Table 36. Global Enasidenib Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Enasidenib Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Enasidenib Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Enasidenib Drugs Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Enasidenib Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Enasidenib Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Enasidenib Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Enasidenib Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Enasidenib Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Enasidenib Drugs Sales Volume by Region (Units): 2019 VS 2023 VS 2030
    Table 46. Global Enasidenib Drugs Sales Volume by Region (2019-2024) & (Units)
    Table 47. Global Enasidenib Drugs Sales Volume by Region (2025-2030) & (Units)
    Table 48. Global Enasidenib Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Enasidenib Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Enasidenib Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Enasidenib Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Enasidenib Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Enasidenib Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Enasidenib Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Enasidenib Drugs Sales Volume, (2019-2024) & (Units)
    Table 56. Key Countries/Regions Enasidenib Drugs Sales Volume, (2025-2030) & (Units)
    Table 57. Bristol Myers Squibb Company Information
    Table 58. Bristol Myers Squibb Introduction and Business Overview
    Table 59. Bristol Myers Squibb Enasidenib Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Bristol Myers Squibb Enasidenib Drugs Product Offerings
    Table 61. Bristol Myers Squibb Recent Development
    Table 62. Key Raw Materials Lists
    Table 63. Raw Materials Key Suppliers Lists
    Table 64. Enasidenib Drugs Downstream Customers
    Table 65. Enasidenib Drugs Distributors List
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Enasidenib Drugs Product Picture
    Figure 2. Global Enasidenib Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Enasidenib Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Enasidenib Drugs Sales Volume (2019-2030) & (Units)
    Figure 5. Global Enasidenib Drugs Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Enasidenib Drugs Report Years Considered
    Figure 7. Global Enasidenib Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Enasidenib Drugs Players Sales Volume Ranking (2023) & (Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Enasidenib Drugs Revenue in 2023
    Figure 10. Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 50mg Picture
    Figure 12. 100mg Picture
    Figure 13. Global Enasidenib Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Enasidenib Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Enasidenib Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)
    Figure 16. Global Enasidenib Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Enasidenib Drugs Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Pharmacy
    Figure 20. Global Enasidenib Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Enasidenib Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Enasidenib Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)
    Figure 23. Global Enasidenib Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Enasidenib Drugs Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America Enasidenib Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Enasidenib Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Enasidenib Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Enasidenib Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Enasidenib Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Enasidenib Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Enasidenib Drugs Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Enasidenib Drugs Sales Volume (%), (2019-2030)
    Figure 37. United States Enasidenib Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Enasidenib Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Enasidenib Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Enasidenib Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Enasidenib Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Enasidenib Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Enasidenib Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Enasidenib Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Enasidenib Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Enasidenib Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Enasidenib Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Enasidenib Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Enasidenib Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Enasidenib Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Enasidenib Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. Enasidenib Drugs Industrial Chain
    Figure 59. Enasidenib Drugs Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23Z18292
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14Z15017
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7M18883
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37J14968
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions